News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
212,096 Results
Type
Article (20100)
Company Profile (94)
Press Release (191890)
Multimedia
Podcasts (50)
Webinars (20)
Section
Business (71351)
Career Advice (843)
Deals (9031)
Drug Delivery (86)
Drug Development (18798)
Employer Resources (147)
FDA (3417)
Job Trends (6132)
News (95296)
Policy (7100)
Tag
2027 BioCapital Elite (1)
2027 BioCapital Standard (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (2)
2027 Biotech Beach Elite (1)
2027 Biotech Beach Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (4)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (7)
Academia (1541)
Academic (2)
Accelerated approval (25)
ADA (17)
Adcomms (18)
Allergies (51)
Alliances (17375)
ALS (80)
Alzheimer's disease (778)
Antibody-drug conjugate (ADC) (186)
Approvals (3640)
Artificial intelligence (412)
ASCO (103)
Autoimmune disease (140)
Automation (36)
Bankruptcy (52)
Belgium (2)
Best Places to Work (4884)
BIO (31)
Biologics (5)
BIOSECURE Act (12)
Biosimilars (92)
BioSpace Insights (123)
Biotechnology (55)
Bladder cancer (59)
Brain cancer (22)
Breast cancer (266)
Cancer (1967)
Cardiovascular disease (214)
Career advice (777)
Career pathing (48)
CAR-T (128)
CDC (26)
CDMO (51)
Cell therapy (353)
Cervical cancer (19)
Clinical research (15984)
Collaboration (1088)
Commercialization (4)
Company closure (1)
Compensation (246)
Complete response letters (26)
COVID-19 (1022)
CRISPR (69)
C-suite (864)
Cystic fibrosis (60)
Data (2960)
Decentralized trials (2)
Denatured (32)
Depression (62)
Dermatology (52)
Diabetes (197)
Diagnostics (2666)
Digital health (25)
Diversity (10)
Diversity, equity & inclusion (37)
Drug discovery (233)
Drug pricing (58)
Drug shortages (6)
Duchenne muscular dystrophy (105)
Earnings (16207)
Editorial (24)
Employer branding (23)
Employer resources (127)
Events (32433)
Executive appointments (714)
FDA (4681)
Fibrodysplasia Ossificans Progressiva (4)
Friedreich's ataxia (12)
Frontotemporal dementia (8)
Funding (1023)
Gene editing (124)
Generative AI (42)
Gene therapy (257)
GLP-1 (389)
Government (1450)
Guidances (133)
Healthcare (5035)
Hematology (67)
HIV (63)
Huntington's disease (29)
Idiopathic pulmonary fibrosis (1)
IgA nephropathy (35)
Immunology and inflammation (82)
Immuno-oncology (30)
Indications (72)
Infectious disease (1168)
Inflammatory bowel disease (91)
Inflation Reduction Act (8)
Influenza (48)
Intellectual property (93)
Interviews (125)
IPO (3659)
IRA (17)
Job creations (1319)
Job search strategy (648)
JPM (28)
Kidney cancer (5)
Labor market (109)
Layoffs (219)
Leadership (26)
Legal (1185)
Licensing (7)
Liver cancer (29)
Longevity (22)
Lung cancer (241)
Lymphoma (186)
Machine learning (34)
Management (46)
Manufacturing (502)
Marketing (1)
MASH (44)
Medical affairs (2)
Medical device (2756)
Medtech (2812)
Mergers & acquisitions (5964)
Metabolic disorders (469)
mRNA (89)
Multiple sclerosis (99)
NASH (9)
Netherlands (3)
Neurodegenerative disease (179)
Neuropsychiatric disorders (30)
Neuroscience (1397)
Neurotech (1)
NextGen: Class of 2026 (2085)
Non-profit (1709)
Now hiring (85)
Obesity (218)
Opinion (159)
Ovarian cancer (61)
Pain (94)
Pancreatic cancer (73)
Parkinson's disease (136)
Partnered (21)
Patents (143)
Patient recruitment (217)
Peanut (19)
People (28972)
Peptides (2)
Pharmaceutical (22)
Pharmacy benefit managers (3)
Phase 1 (4673)
Phase 2 (6574)
Phase 3 (6300)
Pipeline (3592)
Policy (129)
Postmarket research (557)
Preclinical (2634)
Press Release (61)
Prostate cancer (107)
Psychedelics (31)
Radiopharmaceuticals (93)
Rare diseases (391)
Real estate (2567)
Recruiting (61)
Regulatory (6267)
Reports (49)
Research institute (1344)
Resumes & cover letters (110)
Rett syndrome (6)
RNA editing (11)
RSV (50)
Schizophrenia (66)
Series A (198)
Series B (123)
Service/supplier (6)
Sickle cell disease (48)
Special edition (15)
Spinal muscular atrophy (60)
Sponsored (21)
Startups (2047)
State (1)
Stomach cancer (6)
Supply chain (48)
Tariffs (17)
The Weekly (18)
Vaccines (375)
Venture capital (105)
Weight loss (127)
Women's health (75)
Worklife (21)
Date
Last 7 days (207)
Last 30 days (744)
Last 365 days (10204)
2026 (7337)
2025 (9644)
2024 (11360)
2023 (12947)
2022 (15519)
2021 (17634)
2020 (16243)
2019 (14944)
2018 (10796)
2017 (10276)
2016 (10148)
2015 (10838)
2014 (7985)
2013 (6918)
2012 (7346)
2011 (7526)
2010 (7014)
Location
Africa (332)
Alabama (36)
Alaska (4)
Arizona (118)
Arkansas (4)
Asia (11964)
Australia (2067)
California (4632)
Canada (1403)
China (476)
Colorado (230)
Connecticut (143)
Delaware (222)
Europe (31274)
Florida (649)
Georgia (140)
Hawaii (3)
Idaho (12)
Illinois (321)
India (55)
Indiana (356)
Iowa (17)
Japan (269)
Kansas (49)
Kentucky (17)
Louisiana (14)
Maine (12)
Maryland (431)
Massachusetts (3713)
Michigan (153)
Minnesota (231)
Mississippi (5)
Missouri (60)
Montana (6)
Nebraska (10)
Nevada (45)
New Hampshire (17)
New Jersey (1341)
New Mexico (19)
New York (1455)
North Carolina (732)
North Dakota (10)
Northern California (2516)
Ohio (161)
Oklahoma (13)
Oregon (24)
Pennsylvania (741)
Puerto Rico (11)
Rhode Island (19)
South America (393)
South Carolina (14)
Southern California (1654)
Tennessee (97)
Texas (671)
United States (16874)
Utah (94)
Vermont (1)
Virginia (127)
Washington D.C. (31)
Washington State (373)
West Virginia (1)
Wisconsin (108)
Wyoming (1)
212,096 Results for "myovant sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Immunology and inflammation
AB Science ends 3 studies in multiple sclerosis, other immune conditions
The trials, which were testing the tyrosine kinase inhibitor masitinib, had previously been paused. AB Science’s decision not to resume them was a matter of prioritization, not safety, the biotech said.
July 13, 2026
·
2 min read
·
Tristan Manalac
Deals
Sumitovant Biopharma Completes Acquisition of Myovant Sciences
Sumitovant Biopharma Ltd. (“Sumitovant”) and Myovant Sciences Ltd. (“Myovant”) announced today that Sumitovant has successfully completed its acquisition of Myovant originally announced October 23, 2022.
March 10, 2023
·
5 min read
Press Releases
L7 Informatics Advocates for Neuro-Symbolic AI in Regulated Life Sciences
L7 Informatics’ position is that generative AI has been deployed in regulated science with only half the architecture it needs, and that the missing half is an active knowledge graph generated at the point of execution.
July 23, 2026
·
1 min read
Press Releases
Kivo Joins Experts at RAPS San Francisco to Report on Real-World AI Use Cases in Life Sciences
Seven speakers bring seven real-world AI stories to one stage, exploring how human expertise and intelligent automation are reshaping life sciences.
July 17, 2026
·
1 min read
Job Trends
Employment and funding growth fell in 2025: California Life Sciences report
California life sciences jobs declined 1.8% last year, according to the new California Life Sciences sector report. While National Institutes of Health funding and venture capital investment rose, their growth slowed from the previous year.
May 15, 2026
·
2 min read
·
Angela Gabriel
Business
Myovant Sciences Cancels Second Quarter Earnings Conference Call
Myovant Sciences (NYSE: MYOV) (“Myovant”) today announced the cancellation of its earnings conference call for the quarter ended September 30, 2022 that had originally been scheduled for October 26, 2022 at 5:00 p.m. Eastern Time.
October 24, 2022
·
1 min read
Press Releases
Clinical Science Update | New Clinical Evidence for ClotChek™
September 8, 2026
·
2 min read
Biotech Bay
Myovant Sciences to Participate at Upcoming September 2022 Investor Conferences
Myovant Sciences announced that David Marek, Chief Executive Officer of Myovant Sciences, Inc., and Uneek Mehra, Chief Financial and Business Officer, will participate in the following upcoming investor conferences.
September 2, 2022
·
2 min read
Startups
10 life sciences startups selected for accelerator program
Seven of the 10 companies participating in the fall cohorts of MassBio and SCbio’s Drive program are based in the United States, including four in Massachusetts.
September 4, 2026
·
2 min read
·
Angela Gabriel
Press Releases
Noveris Health Sciences Joins BioAlberta
July 30, 2026
·
4 min read
1 of 21,210
Next
